MRMaria José Alves Rocha

Maria José Alves Rocha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maria José Alves Rocha has a total of 330 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Salivary Cytokine Profile in Patients with Oral Lichen Planus

    by Janaina Silva Martins Humberto, Rafael Simone Saia, Luis Henrique Angenendt Costa, Maria José Alves Rocha, Ana Carolina Fragoso Motta

    This study aimed to determine salivary concentrations of interleukin (IL)-1β, IL-2, IL-10, IL-23, transforming growth factor (TGF)-β, tumor necrosis factor (TNF)-α, nitrate (a by-product of nitric oxide oxidation), and cortisol in patients with oral lichen planus (OLP). Twenty patients diagnosed with OLP and 20 sex-matched healthy volunteers (HV) were included in this cross-sectional study. Unstimulated whole saliva was collected in the morning. Salivary cytokine and cortisol concentrations were determined by enzyme-linked immunosorbent assays (ELISA). Nitrate was measured in a nitric oxide analyzer. We found higher salivary concentrations of IL-2 (p<0.003), IL-23 ( p<0.04), and TGF-β (p=0.05) in patients with OLP compared to HV. No significant differences were found in salivary levels of TNF-α, IL-1β, or IL-10. Nitrate concentrations were markedly increased in OLP patients (1,227.0 ± 738.8 µM/mg total protein) when compared to HV (261.6 ± 166.8 µM/mg; p<0.0001). Salivary cortisol levels were also higher in OLP patients (2.79 ± 1.39 vs. 1.94 ±1.21 ng/mg; p<0.048). The markedly increased salivary levels of nitric oxide in patients with OLP suggest a relationship of this molecule with the cell death and tissue damage observed in these lesions.


  • Corticosterone and Adrenocorticotrophic Hormone Secretion Is Recovered after Immune Challenge or Acute Restraint Stress in Sepsis Survivor Animals

    by Nilton Nascimento dos Santos-Junior, Luis Henrique Angenendt da Costa, Carlos Henrique Rocha Catalão, Maria José Alves Rocha

    Background: Clinical and experimental studies report a dysregulation of hypothalamus-pituitary-adrenal (HPA) axis during sepsis that causes impairment in hormone secretion in the late phase contributing for the pathophysiology of the disease. However, it is unclear whether this alteration persists even after the disease remission. Methods: We evaluated the effect of an immune challenge or restraint stress on the hormone secretion of HPA axis in sepsis survivor rats. Sepsis was induced by cecal ligation-puncture (CLP) surgery. Naive or animals that survive 5 or 10 days after CLP were submitted to lipopolysaccharide (LPS) injection or restraint stress. After 60 min, blood was collected for plasma nitrate, cytokines, adrenocorticotropic hormone (ACTH), and corticosterone (CORT) and brain for synaptophysin and hypothalamic cytokines. Results: Five days survivor animals showed increased plasma nitrate (p < 0.001) and interleukin (IL)-1β levels (p < 0.05) that were abolished in the 10 days survivors. In the hypothalamus of both survivors, the reverse was seen with IL-6 increased (p < 0.01), while IL-1β did not show any alteration. Synaptophysin expression was reduced in both survivors and did not change after any stimuli. Only the LPS administration increased plasma and/or inflammatory mediators levels in both groups (survivors and naive) being apparently lower in the survivors. There was no difference in the increased secretion pattern of ACTH and CORT observed in the naive and sepsis survivor animals submitted to immune challenge or restraint stress. Conclusion: We conclude that the HPA axis is already recovered soon after 5 days of sepsis induction responding with normal secretion of ACTH and CORT when required.


  • Microglial Activation Modulates Neuroendocrine Secretion During Experimental Sepsis

    by Luis Henrique Angenendt da Costa, Nilton Nascimento Santos-Junior, Carlos Henrique Rocha Catalão, Maria José Alves Rocha

    Sepsis promotes an inflammatory state in the central nervous system (CNS) that may cause autonomic, cognitive, and endocrine changes. Microglia, a resident immune cell of the CNS, is activated in several brain regions during sepsis, suggesting its participation in the central alterations observed in this disease. In this study, we aimed to investigate the role of microglial activation in the neuroendocrine system functions during systemic inflammation. Wistar rats received an intracerebroventricular injection of the microglial activation inhibitor minocycline (100 μg/animal), shortly before sepsis induction by cecal ligation and puncture. At 6 and 24 h after surgery, hormonal parameters, central and peripheral inflammation, and markers of apoptosis and synaptic function in the hypothalamus were analyzed. The administration of minocycline decreased the production of inflammatory mediators and the expression of cell death markers, especially in the late phase of sepsis (24 h). With respect to the endocrine parameters, microglial inhibition caused a decrease in oxytocin and an increase in corticosterone and vasopressin plasma levels in the early phase of sepsis (6 h), while in the late phase, we observed decreased oxytocin and increased ACTH and corticosterone levels compared to septic animals that did not receive minocycline. Prolactin levels were not affected by minocycline administration. The results indicate that microglial activation differentially modulates the secretion of several hormones and that this process is associated with inflammatory mediators produced both centrally and peripherally.


  • Simvastatin Prevents Long-Term Cognitive Deficits in Sepsis Survivor Rats by Reducing Neuroinflammation and Neurodegeneration

    by Carlos Henrique Rocha Catalão, Nilton Nascimento Santos-Junior, Luís Henrique Angenendt da Costa, Anderson Oliveira Souza, Evelin Capellari Cárnio, Adriano Sebollela, Luciane Carla Alberici, Maria José Alves Rocha

    Sepsis-associated encephalopathy causes brain dysfunction that can result in cognitive impairments in sepsis survivor patients. In previous work, we showed that simvastatin attenuated oxidative stress in brain structures related to memory in septic rats. However, there is still a need to evaluate the long-term impact of simvastatin administration on brain neurodegenerative processes and cognitive damage in sepsis survivors. Here, we investigated the possible neuroprotective role of simvastatin in neuroinflammation, and neurodegeneration conditions of brain structures related to memory in rats at 10 days after sepsis survival. Male Wistar rats (250–300 g) were submitted to cecal ligation and puncture (CLP, n = 42) or remained as non-manipulated (naïve, n = 30). Both groups were treated (before and after the surgery) by gavage with simvastatin (20 mg/kg) or an equivalent volume of saline and observed for 10 days. Simvastatin-treated rats that survived to sepsis showed a reduction in the levels of nitrate, IL1-β, and IL-6 and an increase in Bcl-2 protein expression in the prefrontal cortex and hippocampus, and synaptophysin only in the hippocampus. Immunofluorescence revealed a reduction of glial activation, neurodegeneration, apoptosis, and amyloid aggregates confirmed by quantification of GFAP, Iba-1, phospho Ser396-tau, total tau, cleaved caspase-3, and thioflavin-S in the prefrontal cortex and hippocampus. In addition, treated animals presented better performance in tasks involving habituation memory, discriminative, and aversive memory. These results suggest that statins exert a neuroprotective role by upregulation of the Bcl-2 and gliosis reduction, which may prevent the cognitive deficit observed in sepsis survivor animals.


  • Open Access

    HSP-Target of Therapeutic Agents in Sepsis Treatment

    by Anderson Vulczak, Carlos Henrique Rocha Catalão, Luiz Alexandre Pedro de Freitas, Maria José Alves Rocha

    Sepsis is a syndrome characterized by a dysregulated inflammatory response, cellular stress, and organ injury. Sepsis is the main cause of death in intensive care units worldwide, creating need for research and new therapeutic strategies. Heat shock protein (HSP) analyses have recently been developed in the context of sepsis. HSPs have a cytoprotection role in stress conditions, signal to immune cells, and activate the inflammatory response. Hence, HSP analyses have become an important focus in sepsis research, including the investigation of HSPs targeted by therapeutic agents used in sepsis treatment. Many therapeutic agents have been tested, and their HSP modulation showed promising results. Nonetheless, the heterogeneity in experimental designs and the diversity in therapeutic agents used make it difficult to understand their efficacy in sepsis treatment. Therefore, future investigations should include the analysis of parameters related to the early and late immune response in sepsis, HSP localization (intra or extracellular), and time to the onset of treatment after sepsis. They also should consider the differences in experimental sepsis models. In this review, we present the main results of studies on therapeutic agents in targeting HSPs in sepsis treatment. We also discuss limitations and possibilities for future investigations regarding HSP modulators.


  • Neuroprotective action of Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) acids on Paraquat intoxication in Drosophila melanogaster

    by Anderson de Oliveira Souza, Carlos Antônio Couto-Lima, Carlos Henrique Rocha Catalão, Nilton Nascimento Santos-Júnior, Júlia Fernanda dos Santos, Maria Jose Alves da Rocha, Luciane Carla Alberici


  • Experimental sepsis induces sustained inflammation and acetylcholinesterase activity impairment in the hypothalamus

    by N.N. Santos-Junior, C.H.R. Catalão, L.H.A. Costa, A.O. Souza, C.M.D. Mota, L.C. Alberici, L.G.S. Branco, M.J.A. Rocha


  • Alterations in hypothalamic synaptophysin and death markers may be associated with vasopressin impairment in sepsis survivor rats

    by N. N. Santos‐Junior, C. H. R. Catalão, L. H. A. Costa, B. B. Rossignolli, R. C. Dos‐Santos, D. C. Malvar, A. S. Mecawi, M. J. A. Rocha

    The impairment in arginine vasopressin (AVP) secretion during sepsis is described in clinical and experimental studies and has been associated with oxidative stress, apoptosis and diminished activation of hypothalamic neurones. However, few studies have assessed these abnormalities in sepsis survivors. In the present study, we performed 2 sets of experiments on Wistar rats that had been subjected to sepsis by cecal ligation and puncture (CLP) or nonmanipulated (naive) as a control. In the first set, tissues and blood were collected from survivor rats 10 days after CLP to quantify hypothalamic Bcl‐2, cleaved caspase‐3 and synaptophysin contents, as well as bacterial load. In the second set, survivor rats were submitted to an acute osmotic stimulus (hypertonic saline) and, after 30 minutes, water intake and AVP secretion were analysed. The sepsis‐surviving rats did not show bacterial load in tissues, although their hypothalamic synaptophysin and Bcl‐2 levels were decreased and the cleaved caspase‐3 level was increased compared to the control group. However, AVP secretion was significantly attenuated in the CLP survivor animals submitted to an acute osmotic stimulus. These results suggest that the persistent AVP impairment in sepsis survivor animals may be the result hypothalamic dysfunction associated with a synaptic deficit and decreased anti‐apoptotic protein expression.


  • 12th World Congress on Neurohypophysial Hormones, Mangaratiba, Rio de Janeiro, Brazil – 26‐29 July 2017

    by Celia Sladek, Maria José A. Rocha, Mike Ludwig

    This Special Issue of Journal of Neuroendocrinology comprises six reviews and eight original research articles describing recent advances in the field of Vasopressin and Oxytocin hormone research based on presentations given at the 12th World Congress on Neurohypophysial Hormones held in July 2017, in Brazil. We, the Chair of the Local Organising Committee and Guest Editor (Maria José A. Rocha) and Guest/Senior Editors for this issue (Celia Sladek and Mike Ludwig), would like to thank the contributors for their excellent reviews and original research articles, the colleagues who reviewed these articles and the Editorial Board of Journal of Neuroendocrinology for their enthusiastic support of the Special Issue.

  • Direct Immunofluorescence as a Helpful Tool for the Differential Diagnosis of Oral Lichen Planus and Oral Lichenoid Lesions

    by Yasmin Dds Yamanaka, Maurício Yamashita, Lara M. A. Dds Innocentini, Leandro D. Dds Macedo, Fernando Chahud, Alfredo Ribeiro-Silva, Ana Maria Roselino, Maria José A. Rocha, Ana Carolina Dds Motta

    A great number of lichenoid lesions have overlapping clinicopathological features, so the use of adjunct tests to establish definitive diagnosis is recommended for correct management and prognosis of the lesions. In this context, direct immunofluorescence (DIF) can be a useful tool. Thus, this study aimed to characterize the clinical, histopathological, and DIF pattern in patients with oral lichen planus (OLP) and patients with oral lichenoid lesions (OLLs). Patients with OLP and patients with OLL were characterized and compared with patients with mucous membrane pemphigoid, pemphigus vulgaris, and fibrous hyperplasia through a cross-sectional study. Patients with OLP (n = 30) and patients with OLL (n = 26) were mostly white women in the fifth decade of age, with reticular lesions mainly on the buccal mucosa. All patients with OLP and half of the patients with OLL showed liquefaction degeneration at the basal cell layer and a band-like lymphocytic infiltrate in the subepithelial tissue. Twenty-two patients with OLP (73.3%), 10 with OLL (38.4%), 25 with mucous membrane pemphigoid (96.1%), and all with pemphigus vulgaris (100%) had positive DIF. There was no positive DIF in patients with fibrous hyperplasia. The most frequent DIF pattern in patients with OLP and patients with OLL was linear fibrinogen at the basement membrane zone, and a logistic regression model for positive DIF found statistically significant difference in OLP versus OLL (odds ratio, 3.73; confidence interval, 1.23–11.38). Although clinical and histopathological features are sufficient for diagnosing most of the patients with OLP and OLL, DIF is a key tool in differentiating some lichenoid lesions and could improve the diagnosis of OLP and OLL, especially in lesions showing typical clinical and histological features of OLP.